Securities Registration: Employee Benefit Plan (s-8)
June 13 2022 - 4:50PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission
on June 13, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Vicarious Surgical
Inc.
(Exact name of registrant as specified in its
charter)
Delaware |
|
87-2678169 |
(State or other jurisdiction of
incorporation or organization) |
|
(IRS Employer
Identification No.) |
78 Fourth Avenue
Waltham, Massachusetts 02451
(Address, including zip code, of registrant’s
principal executive offices)
2021 Equity Incentive Plan, as amended
(Full Title of the Plan)
Adam Sachs
Chief Executive Officer
Vicarious Surgical Inc.
78 Fourth Avenue
Waltham, Massachusetts 02451
Telephone: (617) 868-1700
(Name, address and telephone number, including
area code, of agent for service)
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging
growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☐ |
Accelerated filer |
☐ |
Non-accelerated filer |
☒ |
Smaller reporting company |
☒ |
|
Emerging growth company |
☒ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
☐
EXPLANATORY NOTE
This Registration Statement
on Form S-8 (this “Registration Statement”) registers an aggregate of 6,590,000 additional shares of Class A common
stock, par value $0.0001 per share (the “Class A common stock”), of Vicarious Surgical Inc. (the “Registrant”)
for issuance under the Vicarious Surgical Inc. 2021 Equity Incentive Plan, as amended, which was approved by the Registrant’s stockholders
at the Registrant’s annual meeting of stockholders on June 1, 2022. This Registration Statement registers additional securities
of the same class as other securities for which the registration statement filed on Form S-8 (SEC File No. 333-261455) of the Registrant
is effective. The information contained in the Registrant’s registration statement on Form S-8 filed with the Securities and Exchange
Commission on December 2, 2021 (SEC File No. 333-261455) is hereby incorporated by reference pursuant to General Instruction E of Form
S-8.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Exhibit
Number |
|
Exhibit Description |
|
Filed
Herewith |
|
Incorporated by
Reference herein from
Form or Schedule |
|
Filing Date |
|
SEC File/
Reg.
Number |
4.1 |
|
Certificate of Incorporation of Vicarious Surgical Inc. |
|
|
|
Form 8-K
(Exhibit 3.1) |
|
9/23/2021 |
|
001-39384 |
|
|
|
|
|
|
|
|
|
|
|
4.2 |
|
Amended and Restated Bylaws of Vicarious Surgical Inc. |
|
|
|
Form 8-K
(Exhibit 3.2) |
|
9/23/2021 |
|
001-39384 |
|
|
|
|
|
|
|
|
|
|
|
4.3 |
|
Specimen Class A Common Stock Certificate. |
|
|
|
Form 8-K
(Exhibit 4.1) |
|
9/23/2021 |
|
001-39384 |
|
|
|
|
|
|
|
|
|
|
|
4.4 |
|
Warrant Agreement, dated as of July 14, 2020, by and between Vicarious Surgical Inc. (formerly D8 Holdings Corp.) and Continental Stock Transfer & Trust Company |
|
|
|
Form 8-K
(Exhibit 4.1) |
|
7/17/2020 |
|
001-39384 |
|
|
|
|
|
|
|
|
|
|
|
5.1 |
|
Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.1 |
|
Consent of Deloitte & Touche LLP, independent registered public accounting firm of Vicarious Surgical Inc. |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.2 |
|
Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in Exhibit 5.1) |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.1 |
|
Power of Attorney (included on the signature page hereof) |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.1+ |
|
Vicarious Surgical Inc. 2021 Equity Incentive Plan, as amended, and forms of agreement thereunder |
|
|
|
Form 8-K
(Exhibit 10.1) |
|
6/3/2022 |
|
001-39384 |
|
|
|
|
|
|
|
|
|
|
|
107 |
|
Filing Fee Table |
|
X |
|
|
|
|
|
|
+ | Denotes management contract or compensatory plan or arrangement |
Signatures
Pursuant to the requirements of the Securities
Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form S-8 and has duly caused this registration statement on Form S-8 to be signed on its behalf by the undersigned, thereunto
duly authorized in the City of Waltham, State of Massachusetts, on June 13, 2022.
|
VICARIOUS SURGICAL INC. |
|
|
|
|
By: |
/s/ Adam Sachs |
|
|
Adam Sachs |
|
|
Chief Executive Officer |
POWER OF ATTORNEY
Each person whose signature appears below constitutes
and appoints each of Adam Sachs and William Kelly, acting alone or together with another attorney-in-fact, as his or her true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in his or her name, place and stead,
in any and all capacities, to sign any or all further amendments (including post-effective amendments) to this registration statement,
and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person,
hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or
cause to be done by virtue hereof.
Pursuant to the requirements of the Securities
Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ Adam Sachs |
|
Chief Executive Officer, President and Director |
|
June 13, 2022 |
Adam Sachs |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/ William Kelly |
|
Chief Financial Officer and Treasurer
|
|
June 13, 2022 |
William Kelly |
|
(Principal Financial and Accounting Officer) |
|
|
|
|
|
|
|
/s/ David Styka |
|
Chairman |
|
June 13, 2022 |
David Styka |
|
|
|
|
|
|
|
|
|
/s/ Sammy Khalifa |
|
Director |
|
June 13, 2022 |
Sammy Khalifa |
|
|
|
|
|
|
|
|
|
/s/ Samir Kaul |
|
Director |
|
June 13, 2022 |
Samir Kaul |
|
|
|
|
|
|
|
|
|
/s/ Philip Liang |
|
Director |
|
June 13, 2022 |
Philip Liang |
|
|
|
|
|
|
|
|
|
/s/ Ric Fulop |
|
Director |
|
June 13, 2022 |
Ric Fulop |
|
|
|
|
|
|
|
|
|
/s/ Dror Berman |
|
Director |
|
June 13, 2022 |
Dror Berman |
|
|
|
|
|
|
|
|
|
/s/ Donald Tang |
|
Director |
|
June 13, 2022 |
Donald Tang |
|
|
|
|
|
|
|
|
|
/s/ David Ho |
|
Director |
|
June 13, 2022 |
David Ho |
|
|
|
|
2
D8 (NYSE:DEH)
Historical Stock Chart
From Mar 2024 to Apr 2024
D8 (NYSE:DEH)
Historical Stock Chart
From Apr 2023 to Apr 2024